Product Code Database
Dopamantine (, ; developmental code name SCH-15507; also known as N-adamantanoyl dopamine) is an antiparkinsonian drug of the adamantane group that developed for treatment of Parkinson's disease but was never marketed. (1974). 9780120405091, Elsevier. ISBN 9780120405091 It was developed and studied in the 1970s and was said to have reached early .
Dopamantine combines elements of the chemical structures of clinically used adamantane antiparkinsonian agents like amantadine and dopamine or levodopa (L-DOPA) into a single molecule. It is said to have been designed to help dopamine cross the blood–brain barrier via the lipophilicity adamantane moiety. The drug is said to share pharmacology effects with amantadine. Another related compound is carmantadine, which is also an adamantane antiparkinsonian agent that was never marketed.
|
|
